{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"gracile","columns":[{"gene":"","key":"population-64c6f91ca5041781c3bc","label":"Gracile syndrome","mondoId":"MONDO:0011308","onsetQualifier":null,"originColumnKey":"MONDO:0011308/OMIM:603358","originalViews":[{"key":"MONDO:0011308/OMIM:603358","label":"Gracile syndrome","scopeLabel":"OMIM:603358","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["034993f5f1410323722ce8a5993e8c0b2e25d2bc3108ff1f625c16e5255d1b20","18902310e376c44ceb519ec2c3644c46268c4f1a3d66503c161d17ad5093fbb0","1d332707060f8bb19c23ff0f1021778d1b3de6d1dc48a9676bc9d478ee8a8f70","791b975e2ab9abf1a02b805b283e7a6800bd94860a2ca3a4fbf5249287b5e9ee","a09f5098c2d7ec4d2b92c80069fb5c8f0f48e89a9e3131165200baa3c4cee5c4","bea22c413fef8625720aa305ce93ae39946157b219f213d66398c8f4ecb6d70e","d4911873d4669a2b7b0128d17722e2badbc8ddcc7d7e3afcadea422f4debe819","ec86891929f309f043c19d72ba1363141d3ca3d6d0d461cd90c73128fbd67a7e"],"recordQualifiers":{},"scopeLabel":"OMIM:603358","sourceIds":["OMIM:603358"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-aa90c8bbd7b641f0b716","label":"GRACILE syndrome","mondoId":"MONDO:0011308","onsetQualifier":null,"originColumnKey":"MONDO:0011308/ORPHA:53693","originalViews":[{"key":"MONDO:0011308/ORPHA:53693","label":"GRACILE syndrome","scopeLabel":"ORPHA:53693","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["03cb3dd5a2c9155a8bd695a02a331bf25ec32f11871987e93c540fc1265e2b72","3320a83bb2911c76a636ae9ff08e2732eae5e2d92484229c30e3ed84876a2c2a","419199028e504afd311a662dfb52bbdf54ff256432dd27bed33550168572965e","7a682ce140f6b853da3c6bacf1225def72572bc42a907153691fef80ba2a22d5","86653c482a20385a9e17c4b5d60c7aad8b9e5fcd0e6379543eeb950fc4204618","86cfd44dbe6a411d78038fcc3b221c7f4aa64920dcc0cba655004a9f4fad41e4","96010af9ab3e3805a593db4ca352d29b6869eabc9bdde0cc2908670c9a007407","cfa759492d33970e297c90005d0f7824e79abceb5e5ec2c0df50affbd6c6c469","eff9f92951d4d645b3f1de09f67d0feb2fa7e67ea8924c4651a1313ec9b2607d","fc4c1fcbb9cb685408ec2bb19af6ed3e882c06eb397aec5b793dfd710cc37fff"],"recordQualifiers":{},"scopeLabel":"ORPHA:53693","sourceIds":["ORPHA:53693"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-64c6f91ca5041781c3bc","population-aa90c8bbd7b641f0b716"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0003355","HP:0001396","HP:0004925","HP:0001394","HP:0012464","HP:0003452","HP:0012465"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":3,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":18,"sourceGroups":{"orphanet":10,"published":8}},"features":[{"hpoId":"HP:0003355","label":"Aminoaciduria","primary":true},{"hpoId":"HP:0001396","label":"Cholestasis","primary":true},{"hpoId":"HP:0004925","label":"Chronic lactic acidosis","primary":true},{"hpoId":"HP:0001394","label":"Cirrhosis","primary":true},{"hpoId":"HP:0012464","label":"Decreased transferrin saturation","primary":true},{"hpoId":"HP:0003452","label":"Elevated circulating iron concentration","primary":true},{"hpoId":"HP:0012465","label":"Elevated hepatic iron concentration","primary":true},{"hpoId":"HP:0000365","label":"Hearing impairment","primary":false},{"hpoId":"HP:0001397","label":"Hepatic steatosis","primary":false},{"hpoId":"HP:0003281","label":"Increased circulating ferritin concentration","primary":false},{"hpoId":"HP:0003542","label":"Increased circulating pyruvate concentration","primary":false},{"hpoId":"HP:0001511","label":"Intrauterine growth retardation","primary":false},{"hpoId":"HP:0003128","label":"Lactic acidosis","primary":false},{"hpoId":"HP:0001319","label":"Neonatal hypotonia","primary":false},{"hpoId":"HP:0001994","label":"Renal Fanconi syndrome","primary":false}],"ledeHtml":"GRACILE syndrome is a severe disorder that begins before birth. GRACILE stands for the condition&#x27;s characteristic features: growth retardation, aminoaciduria, cholestasis, iron overload, lactic acidosis, and early death.","mondoId":"MONDO:0011308","node":{"canonicalSlug":"gracile","comparisons":[{"documentSha256":"186770c4b91a278ff255c4ffa76be33c3c452489fb975bbeeff5d9b3d50c2385","key":"legacy-gracile","kind":"legacy","label":"GRACILE syndrome","memberIds":["MONDO:0011308"],"mondoId":"MONDO:0011308","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/gracile.186770c4b91a278ff255c4ffa76be33c3c452489fb975bbeeff5d9b3d50c2385.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":["GRACILE syndrome is caused by a mutation in the BCS1L gene. The protein produced from this gene is found in cell structures called mitochondria, which convert the energy from food into a form that cells can use. In mitochondria, the BCS1L protein plays a role in oxidative phosphorylation, which is a multistep process through which cells derive much of their energy. The BCS1L protein is critical for the formation of a group of proteins known as complex III, which is one of several protein complexes involved in oxidative phosphorylation.","The genetic change involved in GRACILE syndrome alters the BCS1L protein, and the abnormal protein is broken down more quickly than the normal protein. What little protein remains is able to help form some complete complex III, although the amount is severely reduced, particularly in the liver and kidneys. As a result, complex III activity and oxidative phosphorylation are decreased in these organs in people with GRACILE syndrome. Without energy, these organs become damaged, leading to many of the features of GRACILE syndrome. It is not clear why a change in the BCS1L gene leads to iron accumulation in people with this condition."],"causesUrl":"https://medlineplus.gov/genetics/condition/gracile-syndrome/#causes","contentForm":"summary","matchMethod":"automatic-preferred-name","name":"GRACILE syndrome","paragraphs":["GRACILE syndrome is a severe disorder that begins before birth. GRACILE stands for the condition's characteristic features: growth retardation, aminoaciduria, cholestasis, iron overload, lactic acidosis, and early death.","In GRACILE syndrome, growth before birth is slow (intrauterine growth retardation). Affected newborns are smaller than average and have an inability to grow and gain weight at the expected rate (failure to thrive). A characteristic of GRACILE syndrome is excess iron in the liver, which likely begins before birth. Iron levels may begin to improve after birth, although they typically remain elevated. Within the first day of life, infants with GRACILE syndrome have a buildup of a chemical called lactic acid in the body (lactic acidosis). They also have kidney problems that lead to an excess of molecules called amino acids in the urine (aminoaciduria). Babies with GRACILE syndrome have cholestasis, which is a reduced ability to produce and release a digestive fluid called bile. Cholestasis leads to irreversible liver disease (cirrhosis) in the first few months of life.","Because of the severe health problems caused by GRACILE syndrome, infants with this condition do not survive for more than a few months, and about half die within a few days of birth."],"reviewed":"2014-03","scope":"exact","scopeNote":"","source":"MedlinePlus","sourceRelease":"2026-10-01","upstream":"MedlinePlus Genetics","url":"https://medlineplus.gov/genetics/condition/gracile-syndrome"},"ownColumnKeys":["population-64c6f91ca5041781c3bc","population-aa90c8bbd7b641f0b716"],"publication":"published","relationships":[{"kind":"parent","label":"hereditary disease","mondoId":"MONDO:0003847","slug":null},{"kind":"parent","label":"mitochondrial disease","mondoId":"MONDO:0044970","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending","articles":[{"articleId":"rarediseases.info.nih.gov/diseases/1","pageMondoId":"MONDO:0011308","source":"GARD","name":"GRACILE syndrome","url":"https://rarediseases.info.nih.gov/diseases/1","relationToPage":"same-condition","coveredMondoIds":["MONDO:0011308"],"status":"validated-exact-source","presentation":"additional-reference","evidence":["existing-offline-scope-validator","automatic-identity-and-attribution"],"reviewed":null,"sourceRelease":"2026-10-21T16:58:24Z","upstream":"GARD:0000001","rawAttribution":"MONDO:0011308","independentCorroborationEstablished":false}]},"records":[{"frequencyKind":"count","key":"034993f5f1410323722ce8a5993e8c0b2e25d2bc3108ff1f625c16e5255d1b20","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:603358","disease_name":"Gracile syndrome","evidence":"PCS","frequency_raw":"3/20","hpo_id":"HP:0001319","is_excluded":false,"label":"Neonatal hypotonia","onset_id":"HP:0003623","reference":"PMID:12215968","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"03cb3dd5a2c9155a8bd695a02a331bf25ec32f11871987e93c540fc1265e2b72","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:53693","disease_name":"GRACILE syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012464","is_excluded":false,"label":"Decreased transferrin saturation","onset_id":null,"reference":"ORPHA:53693","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"18902310e376c44ceb519ec2c3644c46268c4f1a3d66503c161d17ad5093fbb0","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:603358","disease_name":"Gracile syndrome","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001511","is_excluded":false,"label":"Intrauterine growth retardation","onset_id":null,"reference":"PMID:12215968","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"1d332707060f8bb19c23ff0f1021778d1b3de6d1dc48a9676bc9d478ee8a8f70","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:603358","disease_name":"Gracile syndrome","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003452","is_excluded":false,"label":"Elevated circulating iron concentration","onset_id":"HP:0003623","reference":"PMID:12215968","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"3320a83bb2911c76a636ae9ff08e2732eae5e2d92484229c30e3ed84876a2c2a","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:53693","disease_name":"GRACILE syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001396","is_excluded":false,"label":"Cholestasis","onset_id":null,"reference":"ORPHA:53693","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"419199028e504afd311a662dfb52bbdf54ff256432dd27bed33550168572965e","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:53693","disease_name":"GRACILE syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001994","is_excluded":false,"label":"Renal Fanconi syndrome","onset_id":null,"reference":"ORPHA:53693","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"791b975e2ab9abf1a02b805b283e7a6800bd94860a2ca3a4fbf5249287b5e9ee","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:603358","disease_name":"Gracile syndrome","evidence":"PCS","frequency_raw":"19/20","hpo_id":"HP:0001396","is_excluded":false,"label":"Cholestasis","onset_id":"HP:0003623","reference":"PMID:12215968","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"7a682ce140f6b853da3c6bacf1225def72572bc42a907153691fef80ba2a22d5","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:53693","disease_name":"GRACILE syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003128","is_excluded":false,"label":"Lactic acidosis","onset_id":null,"reference":"ORPHA:53693","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"86653c482a20385a9e17c4b5d60c7aad8b9e5fcd0e6379543eeb950fc4204618","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:53693","disease_name":"GRACILE syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012465","is_excluded":false,"label":"Elevated hepatic iron concentration","onset_id":null,"reference":"ORPHA:53693","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"86cfd44dbe6a411d78038fcc3b221c7f4aa64920dcc0cba655004a9f4fad41e4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:53693","disease_name":"GRACILE syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003281","is_excluded":false,"label":"Increased circulating ferritin concentration","onset_id":null,"reference":"ORPHA:53693","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"96010af9ab3e3805a593db4ca352d29b6869eabc9bdde0cc2908670c9a007407","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:53693","disease_name":"GRACILE syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000365","is_excluded":false,"label":"Hearing impairment","onset_id":null,"reference":"ORPHA:53693","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"a09f5098c2d7ec4d2b92c80069fb5c8f0f48e89a9e3131165200baa3c4cee5c4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:603358","disease_name":"Gracile syndrome","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0004925","is_excluded":false,"label":"Chronic lactic acidosis","onset_id":"HP:0003623","reference":"PMID:12215968","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"bea22c413fef8625720aa305ce93ae39946157b219f213d66398c8f4ecb6d70e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:603358","disease_name":"Gracile syndrome","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003542","is_excluded":false,"label":"Increased circulating pyruvate concentration","onset_id":"HP:0003623","reference":"PMID:12215968","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"cfa759492d33970e297c90005d0f7824e79abceb5e5ec2c0df50affbd6c6c469","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:53693","disease_name":"GRACILE syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001397","is_excluded":false,"label":"Hepatic steatosis","onset_id":null,"reference":"ORPHA:53693","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"d4911873d4669a2b7b0128d17722e2badbc8ddcc7d7e3afcadea422f4debe819","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:603358","disease_name":"Gracile syndrome","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003281","is_excluded":false,"label":"Increased circulating ferritin concentration","onset_id":"HP:0003623","reference":"PMID:12215968","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ec86891929f309f043c19d72ba1363141d3ca3d6d0d461cd90c73128fbd67a7e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:603358","disease_name":"Gracile syndrome","evidence":"PCS","frequency_raw":"20/20","hpo_id":"HP:0003355","is_excluded":false,"label":"Aminoaciduria","onset_id":"HP:0003623","reference":"PMID:12215968","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"eff9f92951d4d645b3f1de09f67d0feb2fa7e67ea8924c4651a1313ec9b2607d","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:53693","disease_name":"GRACILE syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001511","is_excluded":false,"label":"Intrauterine growth retardation","onset_id":null,"reference":"ORPHA:53693","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fc4c1fcbb9cb685408ec2bb19af6ed3e882c06eb397aec5b793dfd710cc37fff","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:53693","disease_name":"GRACILE syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001394","is_excluded":false,"label":"Cirrhosis","onset_id":null,"reference":"ORPHA:53693","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/gracile-syndrome\" rel=\"noreferrer\">MedlinePlus</a></p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/1\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011308\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-preferred-name</dd><dt>Upstream attribution</dt><dd>MedlinePlus Genetics</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>GRACILE syndrome is a severe disorder that begins before birth. GRACILE stands for the condition&#x27;s characteristic features: growth retardation, aminoaciduria, cholestasis, iron overload, lactic acidosis, and early death.</p><p>In GRACILE syndrome, growth before birth is slow (intrauterine growth retardation). Affected newborns are smaller than average and have an inability to grow and gain weight at the expected rate (failure to thrive). A characteristic of GRACILE syndrome is excess iron in the liver, which likely begins before birth. Iron levels may begin to improve after birth, although they typically remain elevated. Within the first day of life, infants with GRACILE syndrome have a buildup of a chemical called lactic acid in the body (lactic acidosis). They also have kidney problems that lead to an excess of molecules called amino acids in the urine (aminoaciduria). Babies with GRACILE syndrome have cholestasis, which is a reduced ability to produce and release a digestive fluid called bile. Cholestasis leads to irreversible liver disease (cirrhosis) in the first few months of life.</p><p>Because of the severe health problems caused by GRACILE syndrome, infants with this condition do not survive for more than a few months, and about half die within a few days of birth.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/gracile-syndrome\" rel=\"noreferrer\">MedlinePlus</a></p>","key":"overview","title":"Overview"},{"bodyHtml":"<p>GRACILE syndrome is caused by a mutation in the BCS1L gene. The protein produced from this gene is found in cell structures called mitochondria, which convert the energy from food into a form that cells can use. In mitochondria, the BCS1L protein plays a role in oxidative phosphorylation, which is a multistep process through which cells derive much of their energy. The BCS1L protein is critical for the formation of a group of proteins known as complex III, which is one of several protein complexes involved in oxidative phosphorylation.</p><p>The genetic change involved in GRACILE syndrome alters the BCS1L protein, and the abnormal protein is broken down more quickly than the normal protein. What little protein remains is able to help form some complete complex III, although the amount is severely reduced, particularly in the liver and kidneys. As a result, complex III activity and oxidative phosphorylation are decreased in these organs in people with GRACILE syndrome. Without energy, these organs become damaged, leading to many of the features of GRACILE syndrome. It is not clear why a change in the BCS1L gene leads to iron accumulation in people with this condition.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/gracile-syndrome/#causes\" rel=\"noreferrer\">MedlinePlus</a></p>","key":"causes","title":"Causes"}],"sharedSources":[],"slug":"gracile","sourceDocuments":[{"name":"MedlinePlus: GRACILE syndrome","reviewed":"2014-03","source_release":"2026-10-01","url":"https://medlineplus.gov/genetics/condition/gracile-syndrome"},{"name":"GARD: GRACILE syndrome","reviewed":null,"source_release":"2026-10-21T16:58:24Z","url":"https://rarediseases.info.nih.gov/diseases/1"},{"name":"MONDO: GRACILE syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0011308"}],"sourceNote":"","synonyms":["Fellman disease","Fellman syndrome","Finnish lactic acidosis with hepatic hemosiderosis","Finnish lethal neonatal metabolic syndrome","FLNMS","gracile syndrome","Growth restriction-aminoaciduria-cholestasis-iron overload-lactic acidosis-early death syndrome","Growth retardation, aminoaciduria, cholestasis, iron overload, lactic acidosis and early death"],"takeawayHtml":"","title":"GRACILE syndrome"},"schemaVersion":1}
